Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yoseph Shaaltiel currently holds 585,916 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yoseph Shaaltiel has been a net seller of PLX stock. They have purchased $97.8K and sold $7.2M worth of shares.
Yoseph Shaaltiel's most recent insider trade was on Sep 15, 2016, when they sold 122,162 shares at $0.00 per share.
Yoseph Shaaltiel serves as Executive at Protalix BioTherapeutics, Inc. (PLX). They have executed 27 insider transactions totaling $7.3M over their tenure at the company.
Yoseph Shaaltiel holds the position of Executive at Protalix BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Yoseph Shaaltiel has shown a selling trading pattern, with $97.8K in total purchases and $7.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Yoseph Shaaltiel was on May 2, 2012, when they sold $2.1M worth of PLX shares. This transaction involved 300,000 shares at $7.13 per share.
Yoseph Shaaltiel currently owns 585,916 shares of Protalix BioTherapeutics, Inc. (PLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yoseph Shaaltiel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yoseph Shaaltiel has 27 Form 4 filings on record as an insider at Protalix BioTherapeutics, Inc..
Set alerts for Yoseph Shaaltiel and 40,000+ other insiders.